Look Out Leukemia, TKIs to the Rescue: Updates in the Management of AML

November 11, 2020

The purpose of this learning activity is to provide a thorough overview of the management of AML, with a focus on the agents newly approved in the last decade (i.e. their mechanism of action, side effects, clinical pearls, literature review etc.). After participating in this educational activity, pharmacists will understand the role these agents have in the management of AML.

Target Audience

  • Pharmacists

Learning Objectives

  1. Describe the pathophysiology, cytogenetics, and molecular abnormalities associated with acute myeloid leukemia
  2. Differentiate between historical treatment options and the novel agents approved for the management of acute myeloid leukemia
  3. Evaluate the recent literature regarding recently approved agents for acute myeloid leukemia
  4. Review the mechanisms of action, dosing, side effect profile, and clinical pearls associated with the novel agents

Additional Information

Course summary
Available credit: 
  • 1.00 ACPE Pharmacist
Course opens: 
11/11/2020
Course expires: 
12/28/2020
Event starts: 
11/11/2020 - 7:00am
Event ends: 
11/11/2020 - 8:00am
Cost:
$0.00
University of Rochester Medical Center
Rochester, NY
United States
Relevant financial relationships: Planning committee members and presenters have nothing to disclose
Planning committee members
Linda Thomas, PharmD, BCPS
Pharmacy Residency Coordinator
University of Rochester Medical Center
 
Presenter
Deidre Smith, PharmD
PGY2 Oncology Pharmacy Resident
University of Rochester Medical Center
Joint Accreditation Statement:
 
In support of improving patient care, this activity has been planned and implemented by Vizient, Inc. and University of Rochester Medical Center.  Vizient, Inc. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
____________________________________________
 
Designation Statements:
 
PHARMACY
Vizient, Inc. designates this activity for a maximum of 1.00 ACPE credit hours.
Universal Activity Number: JA0006103-9999-20-215-L01-P

Available Credit

  • 1.00 ACPE Pharmacist

Price

Cost:
$0.00
Please login or register to take this course.